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The Ly-5 alloantigen, originally believed to be restricted to thymocytes and thymus- 
derived (T)  lymphocytes (1), has recently been shown  to be present on most murine 
hematopoietic cells, including prothymocytes and pluripotent stem cells (2).  Immu- 
noprecipitation studies by Michaelson et al.  (3)  demonstrated that  Ly-5 alloantisera 
react  with  high  molecular weight  surface  proteins  of thymocytes  and  spleen  cells. 
Several components  with  apparent  molecular weights  that  ranged  from  175,000  to 
220,000  could  be  resolved  by  sodium  dodecyl  sulfate  (SDS)-polyacrylamide  gel 
electrophoresis.  The  220,000-mol  wt  species  was  found  only  in  spleen  cells  and 
appeared to be derived from bone marrow-derived (B) cells. 
The tissue distribution and biochemical properties of the Ly-5 alloantigen are very 
similar  to  the  d'istribution  and  properties  of the  T200  glycoprotein,  a  major  cell 
surface  glycoprotein  of murine  hematopoietic  cells  that  is  a  dominant  antigen  in 
xenoimmunization (4-6). We report here that Ly-5 alloantisera define a polymorphism 
of the T200 glycoprotein. 
Materials  and  Methods 
Cell Lines.  The cell lines used in these studies were the murine T  cell lymphoma cell line, 
BW5147,  and  two  mutant  cell  lines,  BW5147  (T200-)  and  BW5147PHA'~  1.8, that  were 
derived from BW5147 cells. Further details of the mutant cell lines are given in Results. Cells 
were maintained in Dulbecco's modified Eagle's medium supplemented with 10% horse serum. 
Immunological  Reagents  and Procedures.  Ly-5.1  and  Ly-5.2 alloantisera were prepared as de- 
scribed previously (2).  Monoclonal T200 antibody was obtained from I3/2.3 hybridoma cells 
(6), and monoclonal Thy-1 antibody was obtained from the hybridoma T24/31.7  (7). For trace 
antibody binding assays, monoclonal antibodies were obtained from culture supernates of the 
appropriate hybridoma cells. For immunoprecipitation studies, a  50%  ammonium  sulphate 
fraction of ascitic fluid from tumor-bearing mice was the source of T200 antibody (8). Trace 
antibody binding assays were  performed  as  previously described  (6).  Immunoprecipitation 
studies were carried out with 0.15 M  NaCI-0.01  M  phosphate buffer (pH  7.2)  that contained 
1% Nonidet P-40 (Shell Chemical Co., New York), 1% sodium deoxycholate, and 0.1% SDS to 
solubilize cells. Antibody-antigen complexes were isolated from cell lysates by adsorption to 
fixed Staphylococcus  aureus. These  procedures  were  as  previously reported  (8),  and  give  low 
backgrounds of nonspecific binding. For precipitation of Ly-5 antigen, 5/LI  of alloantiserum 
was used, and antibody-antigen complexes were bound directly to S. aureus. 
Biochemical  Procedures.  Cells were labeled by the glucose oxidase modification of the lacto- 
peroxidase technique (9). Immunoprecipitates were analyzed on 7.5% polyacrylamide gels with 
a  discontinuous buffer system (10).  Autoradiography was performed with fluorescent screens 
* Supported by National Institutes of Health grant CA 17733. 
:~ Supported by National Institutes of Health grants AI 00270 and AI 13374. 
J. Exp. MED. © The Rockefeller University Press • 0022-1007/80/05/1311/06  $1.00 
Volume 151  May 1980  1311-1316 
1311 1312  OMARY, TROWBRIDGE,  AND SCHEID  BRIEF DEFINITIVE REPORT 
onti- Ly-5  onti-T200 
x 
z 
~5 
..J 
--  i  i  i  i 
I0  20  40  80  160:520  640  2  8  52  128  512  2  8  52  t28  ,512 
RECIPROCAL OF ANTIBODY  DILUTION 
FIG.  l.  Binding  of  Ly-5  alloantisera  and  rat  monoclonal  antibodies  to  BW5147 cells  and 
BW5147(T200-) cells. Trace antibody binding assays were carried out as described  in Materials 
and Methods. 12~I-labeled  affinity-purified goat anti-mouse IgG antibody was used to detect binding 
of mouse alloantisera,  whereas  goat  anti-rat  IgG  antibody was  used  to  detect  binding of rat 
monoclonal antibodies. The left-hand panel shows the binding of Ly-5.1 antibody to BW5147 cells 
(O), and BW5147(T200-) cells (O). Also shown is the binding of Ly-5.2 antibody to BW5147 cells 
(I-I) and BW5147(T200-) cells (m). The middle panel shows the binding of T200  antibody to 
parental (O)  and  mutant  cells (0). The  right-hand panel  shows the binding of anti-Thy-I to 
parental (O) and mutant (0) cells. 
(11).  Peptide mapping was carried out exactly as described previously (8).  Briefly, iodinated 
molecules were purified by immunoprecipitation and SDS-polyacrylamide gel electrophoresis. 
The labeled species were extracted from the gels, carboxymethylated, and digested with trypsin. 
Tryptic peptides were then analyzed on 20- × 20-cm thin-layer  cellulose plates by electrophoresis 
in the first dimension followed by chromatography in the second dimension. 
Results 
To investigate the relationship between the Ly-5 alloantigen and  the T200  glyco- 
protein,  we  took advantage of the  availability of a  T200-negative  mutant  cell  line 
derived from BW5147 cells by immunoselection with monoclonal T200 antibody. As 
described elsewhere (R.  Hyman,  I.  S. Trowbridge, and V.  Stallings. Manuscript  in 
preparation.), this mutant, BW5147(T200-), appears to have a defect in the structural 
gene for T200  glyeoprotein, and other surface glycoproteins are expressed in normal 
amounts on the mutant cells. If Ly-5.1  (BW5147  is derived from an AKR  mouse, an 
Ly-5.1 +  strain)  were  expressed on  the  parental  cells but  not  on  the  T200-negative 
mutant  cells, then  this would be strong evidence that  the Ly-5 alloantisera detect a 
polymorphism of T200 glycoprotein. 
The  presence  of the  Ly-5  alloantigen  on  parental  BW5147  cells and  the  T200- 
negative mutant  cells was tested by trace antibody binding and by immunoprecipi- 
tation  studies.  As  shown  in  Fig.  1,  significant  binding of Ly-5.1  antibodies to  the 
parental cell line was detected in the trace antibody binding assay. In contrast,  the 
binding of Ly-5.1  antibodies to BW5147(T200-)  cells was only slightly higher than 
that of Ly-5.2 antibodies used as a  control for nonspecific binding. Monoclonal T200 
antibody bound only to the parental cells, whereas the binding of a  monoclonal Thy- 
1 antibody to the mutant  cells was somewhat  higher than  to the wild-type cells. In 
contrast to the Ly-5.1 alloantiserum, plateau levels of maximal binding were obtained 
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Fro. 2.  Ly-5.1  alloantibody precipitates  an iodinated molecule from BW5147 cells but not from 
BW5147(T200-)  cells. The autoradiograph (8-h exposure) of a  7.5% SDS-polyacrylamide  gel of 
immunoprecipitates  prepared from lysates of iodinated BW5147 eeUs and BW5147(T200-) cells is 
shown. Greater than 10-fold more radioactivity  was precipitated from BW5147 cells by monoclonal 
T200 antibody (52,000 cpm) than by Ly-5.1 alloantiserum  (4,680 epm). Only one-tenth the amount 
of the anti-T200 precipitate from BW5147 cells was loaded relative to the other samples. Gel tracks 
a-d contain immunoprecipitates  from BW5147 cells, and gel tracks e-h contain immunoprecipitates 
from BW5147(T200-) cells. Antibodies: a and f, anti-T200;  b and e, anti-Ly-5.1; c and g, normal 
C57BL mouse serum; and d and h, normal Lewis rat serum. Mr, apparent molecular weight. 
The results of immunoprecipitation studies that employed Ly-5.1  and monoclonal 
T200  antibody are shown  in Fig. 2.  BW5147 cells and BW5147(T200-)mutant  cells 
wet'e  labeled  by  lactoperoxidase-catalzyed idonation  and  cell  lysates prepared  as 
described  in  Materials and  Methods.  Anti-Ly-5.1  serum  specifically precipitated  a 
labeled molecule from lysates of BW5147  cells with an apparent molecular weight of 
200,000  that  comigrated  on  SDS-polyacrylamide with  T200  glycoprotein.  Neither 
antibody precipitated a  labeled species from lysates of BW5147(T200-)  mutant cells. 
To obtain additiofial evidence that  Ly-5 antibodies react with T200  glycoprotein, 
tryptic  peptides  were  prepared  from  the  iodinated  species  precipitated  by  Ly-5 
alloantisera and T200 antibodies and analyzed by two-dimensional peptide mapping. 
The source of labeled antigens for these experiments was the cell line BW5147.PHA R 
1.8, a  phytohemagglutinin-resistant mutant derived from BW5147 cells. As described 
previously  (12),  this  mutant  cell line has  a  defect  in  the synthesis of N-asparagine- 
linked  complex  oligosaccharides. Tryptic  peptides  of iodinated  T200  glycoprotein 
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Fxo.  3.  Comparison of the peptide maps of Ly-5 antigen and T200 glycoprotein. T200 glycoprotein 
and Ly-5,1 antigen were isolated from BW5147.PHA  R 1.8 cells labeled by lactoperoxidase-catalyzed 
iodination by immunoprecipitation and SDS-gel electrophoresis. Tryptic peptides were prepared 
and analyzed on thin-layer cellulose  plates by electrophoresis in the first dimension and chromatog- 
raphy in the second dimension. Additional details are given in Materials and Methods. 
glycoprotein  from  wild-type  cells  by  the  peptide  mapping  procedures  employed, 
presumably because of differences in their oligosaccharide moieties (8). As shown in 
Fig. 3, the peptides obtained from Ly-5 antigen and T200 glycoprotein appeared to 
be identical  (Fig.  3 a  and  b).  This was confirmed by analysis of a  mixture of both 
tryptic digests (Fig. 3 c). 
Discussion 
The  results  reported  here establish  that  alloantisera  that  defined  Ly-5 detect  a 
polymorphism  of T200  glycoprotein, a  major  cell  surface  glycoprotein of murine 
hematopoietic cells originally detected by surface labeling techniques and immuno- 
precipitation with xenoantisera  (4,  5).  We have previously estimated by saturating 
binding  assays  with  a  rat  monoclonal T200  antibody  that  there  are,  on  average, 
~50,000 molecules of T200 glycoprotein on thymocytes and spleen cells and ~25,000 
molecule/cell on  bone  marrow  cells  (6).  Fluorescence-activated cell  analysis  shows 
most cells in these tissues express similar amounts of antigen (7). Thus, Ly-5 is similar 
to other alloantigens of murine lymphocytes, including Thy-1, Lyt-2, and  Lyt-1  in 
that it represents a polymorphism of a glycoprotein present in relative abundance on 
the cell surface (13-15). 
Although the present studies demonstrate that the Ly-5 alloantigen is a  polymor- 
phism of T200 glycoprotein, and thus confirm estimates of the molecular weight of 
the antigen given previously by Michaelson et al. (3), Ewald and McKenzie (16) have 
suggested that Ly-5 was associated with a  130,000-mol wt glycoprotein. The reason 
for the lower estimate of the apparent molecular weight of Ly-5 antigen found in this 
study is not clear, although one possibility is that partial proteolysis of T200 glyco- 
protein occurred during isolation. 
A  high molecular weight glycoprotein, referred to as leukocyte-common antigen, 
has been isolated in the rat  (17).  This molecule appears to be analogous to murine 
T200 glycoprotein, and, recently, a polymorphism of this rat glycoprotein comparable 
with that of the Ly-5 alloantigen in the mouse has been demonstrated  (18).  Alloan- 
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with leukocyte-common antigen even though in direct cytotoxic tests these antisera 
selectively killed thymocytes and T  cells.  It is striking that not only these alloantisera 
in the rat, but also Ly-5 alloantisera and monoclonal T200 antibody (1, 2,  7)  in the 
mouse, selectively kill thymocytes and T  cells despite the fact that in both species the 
glycoprotein with which the antibodies react  are found in similar amounts on most 
hematopoietic cells. The basis of this selective cytotoxicity is not known, although the 
trivial explanation that  there is a  synergistic interaction of each of these antibodies 
with sublytic amounts of anti-rodent T  cell antibodies in the complement source can 
probably be discounted (7). 
Clarification  of the  relationship  between  Ly-5  antigen  and  T200  glycoprotein 
allows a  choice to be made in future studies between the use of alloantisera against 
Ly-5  and  xenogeneic  T200  monoclonal  antibodies,  such  as  the  one  used  in  this 
investigation, which does not discriminate between the Ly-5.1 and Ly-5.2 phenotypes 
(I.  S.  Trowbridge.  Unpublished  results.).  Whereas  Ly-5  alloantisera  should  prove 
useful  for cell  lineage  studies  within  the  murine  hematopoietic system, xenogeneic 
monoclonal antibodies, which are generally of higher affinity than the corresponding 
alloantibodies, are likely to be more valuable for structural studies of T200 glycopro- 
tein (8). 
Summary 
The cell line BW5147, and a mutant T200-negative cell line derived from BW5147, 
were studied by immunoprecipitation and peptide mapping, with xenogeneic mono- 
clonal anti-T200 serum and with Ly-5 alloantiserum. It appears that the Ly-5 system 
defines a structural polymorphism of the cell surface glycoprotein T200, and that the 
monoclonal anti-T200 serum  defines a  feature of T200 that  is common to mice of 
both Ly-5" and Ly-5  b genotypes and may be invariable in the species. 
Received  for publication 19 Februa,y 1980. 
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